Expression in E. coli of finger-domain lacking tissue-type plasminogen activator with high fibrin affinity. 1985

H Kagitani, and M Tagawa, and K Hatanaka, and T Ikari, and A Saito, and H Bando, and K Okada, and O Matsuo

Tissue-type plasminogen activator (t-PA) has a high affinity for fibrin and induces lysis of fibrin (fibrinolysis) on the surface of fibrin without degrading circulating fibrinogen. cDNA for t-PA which lacks the 'finger-domain' (the site for fibrin affinity) was isolated from Detroit 562 cells. Analysis of the nucleotide sequence revealed a lack of the sequences which code for the finger-domain. A plasmid (pDPAT 1) containing the Escherichia coli tac promoter/operator and the cDNA sequence coding for 'finger-domain lacking t-PA' was constructed for expression in E. Coli. The polypeptide so produced was a new type of t-PA lacking finger-domain, but revealed plasminogen activator activity with the function of fibrin affinity.

UI MeSH Term Description Entries
D010960 Plasminogen Activators A heterogeneous group of proteolytic enzymes that convert PLASMINOGEN to FIBRINOLYSIN. They are concentrated in the lysosomes of most cells and in the vascular endothelium, particularly in the vessels of the microcirculation. Extrinsic Plasminogen Activators,Plasminogen Activator,Uterine-Tissue Plasminogen Activator,Uterine Tissue Plasminogen Activator
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D005337 Fibrin A protein derived from FIBRINOGEN in the presence of THROMBIN, which forms part of the blood clot. Antithrombin I
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA

Related Publications

H Kagitani, and M Tagawa, and K Hatanaka, and T Ikari, and A Saito, and H Bando, and K Okada, and O Matsuo
March 1993, The Journal of biological chemistry,
H Kagitani, and M Tagawa, and K Hatanaka, and T Ikari, and A Saito, and H Bando, and K Okada, and O Matsuo
December 1986, The EMBO journal,
H Kagitani, and M Tagawa, and K Hatanaka, and T Ikari, and A Saito, and H Bando, and K Okada, and O Matsuo
February 2012, The Journal of biological chemistry,
H Kagitani, and M Tagawa, and K Hatanaka, and T Ikari, and A Saito, and H Bando, and K Okada, and O Matsuo
January 1983, Nature,
H Kagitani, and M Tagawa, and K Hatanaka, and T Ikari, and A Saito, and H Bando, and K Okada, and O Matsuo
March 1986, Analytical biochemistry,
H Kagitani, and M Tagawa, and K Hatanaka, and T Ikari, and A Saito, and H Bando, and K Okada, and O Matsuo
December 1995, Protein engineering,
H Kagitani, and M Tagawa, and K Hatanaka, and T Ikari, and A Saito, and H Bando, and K Okada, and O Matsuo
June 1992, Journal of molecular biology,
H Kagitani, and M Tagawa, and K Hatanaka, and T Ikari, and A Saito, and H Bando, and K Okada, and O Matsuo
July 1993, Protein engineering,
H Kagitani, and M Tagawa, and K Hatanaka, and T Ikari, and A Saito, and H Bando, and K Okada, and O Matsuo
June 1994, Science in China. Series B, Chemistry, life sciences & earth sciences,
H Kagitani, and M Tagawa, and K Hatanaka, and T Ikari, and A Saito, and H Bando, and K Okada, and O Matsuo
August 1992, The Journal of biological chemistry,
Copied contents to your clipboard!